121 related articles for article (PubMed ID: 9396335)
1. [A case of refractory diarrhea treated with somatostatin analogue].
Ueno Y; Miyoshi Y; Yatoh M; Takemori M; Hirai E; Okamoto M; Nakamura H; Oda Y; Suzuki K; Iwao Y; Watanabe M; Hibi T
Nihon Shokakibyo Gakkai Zasshi; 1997 Nov; 94(11):778-82. PubMed ID: 9396335
[No Abstract] [Full Text] [Related]
2. Severe protein losing enteropathy with intractable diarrhea due to systemic AA amyloidosis, successfully treated with corticosteroid and octreotide.
Fushimi T; Takahashi Y; Kashima Y; Fukushima K; Ishii W; Kaneko K; Yazaki M; Nakamura A; Tokuda T; Matsuda M; Furuya R; Ikeda S
Amyloid; 2005 Mar; 12(1):48-53. PubMed ID: 16076611
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of protein-losing enteropathy due to AA amyloidosis with somatostatin analogue and high dose steroid in ankylosing spondylitis.
Jeong YS; Jun JB; Kim TH; Lee IH; Bae SC; Yoo DH; Park MH; Kim SY
Clin Exp Rheumatol; 2000; 18(5):619-21. PubMed ID: 11072606
[TBL] [Abstract][Full Text] [Related]
4. Severe diabetic diarrhea successfully treated with octreotide, a somatostatin analogue.
Murao S; Hirata K; Ishida T; Takahara J
Endocr J; 1999 Jun; 46(3):477-8. PubMed ID: 10504003
[No Abstract] [Full Text] [Related]
5. [Treatment of chronic non-secretory diarrhea in ileostomy with the long-acting somatostatin analog SMS 201-995].
Müller MK; Breuer NF; Balzer K; Goebell H
Z Gastroenterol; 1988 Mar; 26(3):166-8. PubMed ID: 2900585
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of octreotide but not long-acting somatostatin analogue for severe refractory diabetic diarrhoea.
Corbould A; Campbell J
Diabet Med; 2009 Aug; 26(8):828-9. PubMed ID: 19709156
[No Abstract] [Full Text] [Related]
7. [Somatostatin and its analogs in the treatment of gastrointestinal and liver diseases].
Feu F; Bosch J
Gastroenterol Hepatol; 1996 Feb; 19(2):68-77. PubMed ID: 8616683
[No Abstract] [Full Text] [Related]
8. Use of a long acting somatostatin analogue in controlling ileostomy diarrhoea in infants.
Lamireau T; Galpérine RI; Ohlbaum P; Demarquez JL; Vergnes P; Kurzenne Y; Hehunstre JP
Acta Paediatr Scand; 1990; 79(8-9):871-2. PubMed ID: 2239290
[No Abstract] [Full Text] [Related]
9. Amyloidosis, diarrhea, and a somatostatin analogue.
O'Connor CR; O'Dorisio TM
Ann Intern Med; 1989 Apr; 110(8):665-6. PubMed ID: 2930098
[No Abstract] [Full Text] [Related]
10. Octreotide long-acting formulation (LAR) in chronic loperamide-refractory diarrhea not related to cancer treatment.
Mystakidou K; Katsouda E; Tsilika E; Smyrniotis V; Vassiliou I; Tsiatas M; Vlahos L
Anticancer Res; 2006; 26(3B):2325-8. PubMed ID: 16821610
[TBL] [Abstract][Full Text] [Related]
11. Protein losing enteropathy in systemic lupus erythematosus: role of diet and octreotide.
Ossandon A; Bombardieri M; Coari G; Graziani G; Valesini G
Lupus; 2002; 11(7):465-6. PubMed ID: 12195791
[No Abstract] [Full Text] [Related]
12. Successful treatment of protein-losing enteropathy due to AA amyloidosis with octreotide in a patient with rheumatoid arthritis.
Shin JK; Jung YH; Bae MN; Baek IW; Kim KJ; Cho CS
Mod Rheumatol; 2013 Mar; 23(2):406-11. PubMed ID: 22815005
[TBL] [Abstract][Full Text] [Related]
13. Treatment of severe cryptosporidium-related diarrhea with octreotide in a patient with AIDS.
Katz MD; Erstad BL; Rose C
Drug Intell Clin Pharm; 1988 Feb; 22(2):134-6. PubMed ID: 2894964
[TBL] [Abstract][Full Text] [Related]
14. SMS 201-995, a somatostatin analogue, and diarrhea in the acquired immunodeficiency syndrome (AIDS).
Robinson EN; Fogel R
Ann Intern Med; 1988 Oct; 109(8):680-1. PubMed ID: 2901819
[No Abstract] [Full Text] [Related]
15. Evaluation of the efficacy of octreotide LAR in the treatment of Crohn's disease associated refractory diarrhea.
Martelli L; Colard A; Fontaine F; Deflandre J; Bastens B; Louis E
Scand J Gastroenterol; 2017 May; 52(5):564-569. PubMed ID: 28270045
[TBL] [Abstract][Full Text] [Related]
16. Use of octreotide in the symptomatic management of diarrhea induced by graft-versus-host disease in patients with hematologic malignancies.
Ippoliti C; Champlin R; Bugazia N; Przepiorka D; Neumann J; Giralt S; Khouri I; Gajewski J
J Clin Oncol; 1997 Nov; 15(11):3350-4. PubMed ID: 9363865
[TBL] [Abstract][Full Text] [Related]
17. Octreotide acetate is efficacious and safe in children for treating diarrhea due to chemotherapy but not acute graft versus host disease.
Pai V; Porter K; Ranalli M
Pediatr Blood Cancer; 2011 Jan; 56(1):45-9. PubMed ID: 21108438
[TBL] [Abstract][Full Text] [Related]
18. [Indications for the use of somatostatin and octreotide in digestive pathology].
Zan S; Roy L; Zanon C; Mobiglia A; Mussa B; Raviola P; Mormile C; Ballario R; Giustetto A
Minerva Gastroenterol Dietol; 1996 Jun; 42(2):107-14. PubMed ID: 8962905
[TBL] [Abstract][Full Text] [Related]
19. Octreotide therapy for diarrhoea.
Gilanders IA; Fulton JD; Save VE
Postgrad Med J; 1997 Jan; 73(855):62. PubMed ID: 9039424
[No Abstract] [Full Text] [Related]
20. Resolution of refractory chemotherapy-induced diarrhea (CID) with octreotide long-acting formulation in cancer patients: 11 case studies.
Rosenoff S
Support Care Cancer; 2004 Aug; 12(8):561-70. PubMed ID: 15160318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
